# DESCRIPTION

## FIELD OF THE INVENTION

- introduce plasma membrane proteins as biomarkers

## BACKGROUND OF THE INVENTION

- motivate need for personalized medicine
- describe limitations of current biomarker diagnostic assays
- highlight potential of erythrocyte membrane proteins as biomarkers

## BRIEF DESCRIPTION OF THE INVENTION

- describe method for quantitative measurement of membrane expression level
- outline steps for preparing erythrocyte test sample
- detail binding of CMP binding agent to epitopes
- describe obtaining signal elicited by specific binding
- convert signal into value correlating with CMP expression level
- compare obtained expression level with typical or normal range
- assess condition related to CMP expression

## DEFINITIONS

- define epitope
- define erythrocyte-related terms
- define various biological and statistical terms

## DETAILED DESCRIPTION OF THE INVENTION

- introduce rapid assay method for erythrocyte membrane proteins
- limitations of prior art methods for membrane protein quantitation
- describe advantages of using whole erythrocyte cells in measurement
- outline method for quantitative measurement of membrane protein expression
- describe sample preparation and binding agent addition
- discuss detection methods and controls for binding agent
- provide examples of assay systems for quantitative determination of erythrocyte membrane proteins
- introduce flow cytometry platform
- describe advantages of flow cytometry
- motivate alternative assay formats
- describe plate assay format
- describe ELISA format
- provide example of microplate cellular fluorescence-based assay
- introduce quantitative determination of erythrocyte membrane proteins
- describe preferred embodiments of membrane transporters
- describe preferred embodiments of membrane channels
- describe preferred embodiments of membrane receptors
- provide examples of quantitative determination of membrane proteins

## EXAMPLES

### Example 1

- introduce ABCG2 multidrug transporter
- describe method for quantitative determination of ABCG2 protein
- detail flow cytometry protocol
- describe genetic analysis of ABCG2 polymorphisms and mutations
- present results of ABCG2 expression in erythrocytes
- correlate ABCG2 expression with genetic variants
- discuss Western blot analysis of ABCG2 expression
- summarize significance of ABCG2 expression in personalized medicine

### Example 2

- motivate ABCG2 protein in erythrocyte membrane
- describe method for quantitative determination of ABCG2 protein
- correlate ABCG2 expression with genetic variations

### Example 3

- describe microplate-based quantitative determination of ABCG2 protein

### Example 4

- describe flow cytometry-based quantitative determination of ABCB6 protein

### Example 5

- describe quantitative determination of ABCA1, ABCB1, ABCC1, ABCC3, and ABCC4 proteins

### Example 6

- describe quantitative determination of intracellular and extracellular membrane proteins

### Example 7

- motivate PMCA proteins
- describe flow cytometry method

### Example 8

- describe parallel determination of ABCG2 and ABCB1

### Example 9

- describe Western blot experiments

## INDUSTRIAL APPLICABILITY

- introduce diagnostic tool-kits for determining quantitative expression of plasma membrane proteins as biomarkers in the erythrocyte membrane

